Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Journal of Cellular & Molecular Anesthesia
  4. Articles

  5. Retracted: Magnesium Gargle Versus Ketamine Gargle in Postoperative Sore Throat Pain; A Randomized Placebo-Controlled Clinical Trial [J Cell Mol Anesth. 2020;5(3): e149598]
  6. Scopus by Title (Ref)

Journal of Cellular & Molecular Anesthesia

homeHome
play_arrowCurrent IssuelistAll Issuescheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
push_pinJournal InformationgroupsEditors & BoardspublicIndexing and Listing Sourcesbar_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormcampaignNew Publisher AnnouncementemailSupportphoneContact Us
euroAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Postoperative sore throat: a systematic review*

- Moulder Z.J. , et al.

2. The Effects of Lavender and Rosemary Extracts on Sore Throat and Hoarseness After Endotracheal Intubation in Patients Undergoing Percutaneous Nephrolithotomy: A Randomized Clinical Trial

- Dehghan M. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • New Publisher Announcement
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.